The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.

US drug prices are up to five times higher than in other developed nations. Trump's order requires US drug prices to align ...

Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...

A bold move by US President Donald Trump to slash the cost of prescription drugs in America has sent shockwaves through the ...

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

Global pharmaceutical shares are slumping Monday after President Donald Trump said he is looking to slash the price of ...

Announcement pressures pharma stocks on worries profits will be hit if they have to cut prices in US. Read more at ...

Shares of Alphamab Oncology plunged 14.4% to HK$6.28, leading declines in Hong Kong-listed pharmaceutical stocks.Meanwhile, ...

That decision by one of the nation's largest PBMs triggered fears of a price war in the weight loss drug market and concerns that Zepbound's sales momentum could stall. Shares of Eli Lilly plunged ...

Big move on Thursday as investors in Eli Lilly and ... on obesity drugs and also other established alternative/direct distribution channels). Hence, I believe the downside impact on LLY may ...

Eli Lilly's Zepbound loses CVS coverage to Wegovy, prompting analyst debate on pricing pressures and long-term obesity market ...

Eli Lilly stock might still have a lot of upside to it, despite increasing competition among weight-loss drugs. Rival Novo Nordisk on Thursday announced a deal to make its weight-loss treatment Wegovy ...